Kinetics of galactomannan in surgical patients receiving perioperative piperacillin/tazobactam prophylaxis

Journal of Antimicrobial Chemotherapy

Volumn 58, Issue 4, 2006, Pages 806-810

  Machetti, M ^a,b   Majabo, M J ^b,c   Furfaro, E ^a,b   Solari, N ^b   Novelli, A ^d   Cafiero, F ^b   Viscoli, C ^a,b,c  

^a ADVANCED BIOTECHNOLOGY CENTER   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Antigen detection false positives; Diagnosis interactions; Fungal infections

Indexed keywords

GALACTOMANNAN; PIPERACILLIN PLUS TAZOBACTAM;

ABDOMINAL SURGERY; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BLOOD SAMPLING; CHEMICAL REACTION KINETICS; CLINICAL ARTICLE; DIGESTIVE SYSTEM CANCER; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG INFUSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PERIOPERATIVE PERIOD; STATISTICAL SIGNIFICANCE; SURGICAL INFECTION; SURGICAL PATIENT;

AGED; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTIONS; COLON; FALSE POSITIVE REACTIONS; FEMALE; GASTRECTOMY; HUMANS; KINETICS; MALE; MANNANS; MIDDLE AGED; PENICILLANIC ACID; PIPERACILLIN; RECTUM;

EID: 33748690109     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl334     Document Type: Article

References (14)

1. Maertens J, Van Eldere J, Verhaegen J et al. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J Infect Dis 2002; 186: 1297-306.
2. Stynen D, Goris A, Sarfati J et al. A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis. J Clin Microbiol 1995; 33: 497-500.
3. Adam O, Auperin A, Wilquin F et al. Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies. Clin Infect Dis 2004; 38: 917-20.
4. Bart-Delabesse E, Basile M, Al Jijakli A et al. Detection of Aspergillus galactomannan antigenemia to determine biological and clinical implications of beta-lactam treatments. J Clin Microbiol 2005; 43: 5214-20.
5. Singh N, Obman A, Husain S et al. Reactivity of platelia Aspergillus galactomannan antigen with piperacillin-tazobactam: Clinical implications based on achievable concentrations in serum. Antimicrob Agents Chemother 2004; 48: 1989-92.
6. Sulahian A, Touratier S, Ribaud P. False positive test for Aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. N Engl J Med 2003; 349: 2366-7.
7. Viscoli C, Machetti M, Cappellano P et al. False-positive galactomannan Platelia Aspergillus test results for patients receiving piperacillin-tazobactam. Clin Infect Dis 2004; 38: 913-5.
8. Mennink-Kersten MAS, Klont RR, Ruegebrink D et al. Amoxicillin-clavulanic acid (AMC) and piperacillin-tazobactam (PTZ) contain high molecular weight cross reacting Aspergillus antigen. In: Late-Breaker Abstract of the Forty-forth Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 2004, Abstract M-1684a, p. 17. American Society for Microbiology, Washington, DC, USA.
9. Machetti M, Furfaro E, Viscoli C. Galactomannan in piperacillin-tazobactam: How much and to what extent?. Antimicrob Agents Chemother 2005; 49: 3984-5.
10. Herbrecht R, Letscher-Bru V, Oprea C et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 2002; 20: 1898-906.
11. Walsh TJ, Shoham S, Petraitiene R et al. Detection of galactomannan antigenemia in patients receiving piperacillin/tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction. J Clin Microbiol 2004; 42: 4744-8.
12. Penack O, Schwartz S, Thiel E et al. Lack of evidence that false-positive Aspergillus galactomannan antigen test results are due to treatment with piperacillin-tazobactam. Clin Infect Dis 2004; 39: 1401-2.
13. Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 2005; 5: 609-22.
14. Bennet JE, Friedman MM, Dupont B. Receptor mediated clearance of Aspergillus galactomannan. J Infect Dis 1987; 155: 1005-10.